Viatris Innovation GmbH
Selatogrel
Acute Myocardial Infarction
Countdown
177days
Phase 3 readout · ~ Dec 31, 2026 estimated
What's at stake
Phase 3 trial results for Selatogrel in Acute Myocardial Infarction are due ~ Dec 31, 2026. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· ClinicalTrials.gov
verified 15h ago
“CT.gov NCT04957719: Phase 3 trial, sponsor Viatris Innovation GmbH, drug Selatogrel. Primary completion date 2026-12 (estimated).”